Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 29;14(4):e0215646.
doi: 10.1371/journal.pone.0215646. eCollection 2019.

Evidence of biomechanical and collagen heterogeneity in uterine fibroids

Affiliations

Evidence of biomechanical and collagen heterogeneity in uterine fibroids

Friederike L Jayes et al. PLoS One. .

Abstract

Objective: Uterine fibroids (leiomyomas) are common benign tumors of the myometrium but their molecular pathobiology remains elusive. These stiff and often large tumors contain abundant extracellular matrix (ECM), including large amounts of collagen, and can lead to significant morbidities. After observing structural multiformities of uterine fibroids, we aimed to explore this heterogeneity by focusing on collagen and tissue stiffness.

Methods: For 19 fibroids, ranging in size from 3 to 11 centimeters, from eight women we documented gross appearance and evaluated collagen content by Masson trichrome staining. Collagen types were determined in additional samples by serial extraction and gel electrophoresis. Biomechanical stiffness was evaluated by rheometry.

Results: Fibroid slices displayed different gross morphology and some fibroids had characteristics of two or more patterns: classical whorled (n = 8); nodular (n = 9); interweaving trabecular (n = 9); other (n = 1). All examined fibroids contained at least 37% collagen. Tested samples included type I, III, and V collagen of different proportions. Fibroid stiffness was not correlated with the overall collagen content (correlation coefficient 0.22). Neither stiffness nor collagen content was correlated with fibroid size. Stiffness among fibroids ranged from 3028 to 14180 Pa (CV 36.7%; p<0.001, one-way ANOVA). Stiffness within individual fibroids was also not uniform and variability ranged from CV 1.6 to 42.9%.

Conclusions: The observed heterogeneity in structure, collagen content, and stiffness highlights that fibroid regions differ in architectural status. These differences might be associated with variations in local pressure, biomechanical signaling, and altered growth. We conclude the design of all fibroid studies should account for such heterogeneity because samples from different regions have different characteristics. Our understanding of fibroid pathophysiology will greatly increase through the investigation of the complexity of the chemical and biochemical signaling in fibroid development, the correlation of collagen content and mechanical properties in uterine fibroids, and the mechanical forces involved in fibroid development as affected by the various components of the ECM.

PubMed Disclaimer

Conflict of interest statement

We have the following interests: BioSpecifics Technologies Corporation (BTC) provided partial funding for the work presented here. None of the authors are employed by this company. None of the authors own stock in the company. Two and a half years ago PCL presented findings of a study, now published [Jayes, 2016] to the Board of Directors of the company. PCL is listed on a patent (Phyllis Leppert, Thomas Wegman, Darlene Taylor: Treatment method and product for uterine fibroids using purified collagenase US9744138B2). The proceeds, if any, of this patent are assigned to BTC and a portion of the profit assigned to Duke University. Our submitted manuscript is unrelated to the patent. Our manuscript does not involve the use of collagenase as a treatment. Both PCL and FLJ are involved in a phase I clinical trial of collagenase for fibroid treatment being conducted by James Segars, PI at Johns Hopkins University. There are no further patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.

Figures

Fig 1
Fig 1. Representative photographs of tissue slices showing differences in gross appearance of fibroids.
A: Classical irregular whorled pattern; B, C, D: Patterns of nodules; E, F: Trabecular structures; G: Characteristics of multiple patterns. This example shows a trabecular/nodular pattern; H: Not categorized. This example shows a tightly gyrated pattern. I: Myometrial tissue shown for comparison. Note the seedling fibroid embedded in the tissue (white appearance). Ruler (cm) shown for size.
Fig 2
Fig 2. Representative samples of Masson trichrome-stained fibroid tissues (collagen stained blue-green; muscle cells stained red) examined under digital microscopy (20x).
Samples (approx. 1x1 cm) from 2 different fibroids were chosen representing a high collagen content (A:14–3) and a relatively low collagen content (B:15–2). The circular holes are due to 5 mm punches taken for rheometry before samples were fixed and stained. Collagen was quantified using pixel counts and is denoted underneath each sample.
Fig 3
Fig 3. Stiffness and percent collagen in fibroids.
Columns represent mean tissue stiffness (complex shear modulus [kPa]) in 19 fibroid slices from 8 different subjects. X-axis labels indicate the subject number followed by the fibroid number. Five subjects contributed more than one fibroid to the study. Error bars indicate within-fibroid variability (SD). The pink line represents percent collagen in each fibroid slice as determined by analysis of Masson trichrome staining. The correlation coefficient of stiffness to percent collagen was 0.22.
Fig 4
Fig 4. SDS-PAGE analysis of collagen in a representative fibroid sample.
Lane A: Total collagen extract under non-reducing conditions. Lane B: Total collagen extract under reducing conditions (with TCEP). Lane C: Collagen extract depleted of type V by selective salt precipitation. Lane D: Collagen extract enriched in type V by selective salt precipitation. Sample shown is from 395-E.

References

    1. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–7. Epub 2003/01/28. - PubMed
    1. Stewart EA, Laughlin-Tommaso SK, Catherino WH, Lalitkumar S, Gupta D, Vollenhoven B. Uterine fibroids. Nat Rev Dis Primers. 2016;2:16043 Epub 2016/06/24. 10.1038/nrdp.2016.43 . - DOI - PubMed
    1. Stewart EA, Friedman AJ, Peck K, Nowak RA. Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle. J Clin Endocrinol Metab. 1994;79(3):900–6. Epub 1994/09/01. 10.1210/jcem.79.3.8077380 . - DOI - PubMed
    1. Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol. 1990;94(4):435–8. Epub 1990/10/01. . - PubMed
    1. Konishi I, Fujii S, Ban C, Okuda Y, Okamura H, Tojo S. Ultrastructural study of minute uterine leiomyomas. Int J Gynecol Pathol. 1983;2(2):113–20. Epub 1983/01/01. . - PubMed

Publication types